07:00 , May 7, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Importin 7 (IPO7); MAP kinase 1 (MAPK1; ERK-2); MAPK3 (ERK-1)

Cancer INDICATION: Cancer In vitro and mouse studies suggest a peptide inhibitor of IPO7 binding to MAPK1 or MAPK3 could help treat cancer. In multiple human cancer cell lines, a cell-penetrating peptide derived from MAPK1 and MAPK3...
07:00 , Jul 30, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cardiovascular disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Hypertension Postmeiotic segregation...
07:00 , Jul 13, 2009 |  BioCentury  |  Emerging Company Profile

NanoVector: Planted in the nucleus

NanoVector Inc. believes its plant virus-based nanoparticle technology will allow it to deliver drugs precisely inside targeted cells, reducing side effects and improving the efficacy of chemotherapeutics and other drugs. The technology exploits the chemical sensing...